Moreover, intestinal IL-22 impacting intestinal barrier function, altering the host gut microbiota, and regulating the host expression of fat metabolism genes are additional hypotheses that could explain the observed protection in liver steatosis in Vipr2ΔILC3 mice.7, 10, 18, 40, 44. This evidence concerns the gene IL22 and Hepatic steatosis.